Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

  • Showing results for cros p. Search instead for Ucros P (1 item)
1.

Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature.

Swaminathan A, du Cros P, Seddon JA, Mirgayosieva S, Asladdin R, Dusmatova Z.

BMC Infect Dis. 2017 Jun 12;17(1):417. doi: 10.1186/s12879-017-2499-1.

2.

Effect of Nebulized Hypertonic Saline Treatment in Emergency Departments on the Hospitalization Rate for Acute Bronchiolitis: A Randomized Clinical Trial.

Angoulvant F, Bellêttre X, Milcent K, Teglas JP, Claudet I, Le Guen CG, de Pontual L, Minodier P, Dubos F, Brouard J, Soussan-Banini V, Degas-Bussiere V, Gatin A, Schweitzer C, Epaud R, Ryckewaert A, Cros P, Marot Y, Flahaut P, Saunier P, Babe P, Patteau G, Delebarre M, Titomanlio L, Vrignaud B, Trieu TV, Tahir A, Regnard D, Micheau P, Charara O, Henry S, Ploin D, Panjo H, Vabret A, Bouyer J, Gajdos V; Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis (GUERANDE) Study Group.

JAMA Pediatr. 2017 Jun 5:e171333. doi: 10.1001/jamapediatrics.2017.1333. [Epub ahead of print]

PMID:
28586918
3.

Occupational contact dermatitis from protein in sea products: who is the most affected, the fisherman or the chef?

Loddé B, Cros P, Roguedas-Contios AM, Pougnet R, Lucas D, Dewitte JD, Misery L.

J Occup Med Toxicol. 2017 Feb 10;12:4. doi: 10.1186/s12995-017-0150-0. eCollection 2017.

4.

Respiratory Morbidity in Infants Born With a Congenital Lung Malformation.

Delestrain C, Khen-Dunlop N, Hadchouel A, Cros P, Ducoin H, Fayon M, Gibertini I, Labbé A, Labouret G, Lebras MN, Lezmi G, Madhi F, Thouvenin G, Thumerelle C, Delacourt C.

Pediatrics. 2017 Mar;139(3). pii: e20162988. doi: 10.1542/peds.2016-2988. Epub 2017 Feb 15.

PMID:
28202768
5.

Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.

Trauer JM, Achar J, Parpieva N, Khamraev A, Denholm JT, Falzon D, Jaramillo E, Mesic A, du Cros P, McBryde ES.

BMC Med. 2016 Nov 18;14(1):187.

6.

WHO recommendations for multidrug-resistant tuberculosis.

Berry C, Achar J, du Cros P.

Lancet. 2016 Nov 5;388(10057):2234. doi: 10.1016/S0140-6736(16)32071-2. No abstract available.

PMID:
27825500
7.

Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.

Horter S, Stringer B, Greig J, Amangeldiev A, Tillashaikhov MN, Parpieva N, Tigay Z, du Cros P.

BMC Infect Dis. 2016 Jul 28;16:362. doi: 10.1186/s12879-016-1723-8.

8.

'They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan.

Stringer B, Lowton K, Tillashaikhov M, Parpieva N, Ulmasova D, du Cros P, Hasker E, Sergeeva N.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1084-90. doi: 10.5588/ijtld.15.0815.

PMID:
27393544
9.

Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.

Berry C, Yates TA, Seddon JA, Phillips PP, du Cros P; North London TB Journal Club.

Eur Respir J. 2016 May;47(5):1591-2. doi: 10.1183/13993003.01646-2015. No abstract available.

PMID:
27132271
10.

Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.

Furin J, Alirol E, Allen E, Fielding K, Merle C, Abubakar I, Andersen J, Davies G, Dheda K, Diacon A, Dooley KE, Dravnice G, Eisenach K, Everitt D, Ferstenberg D, Goolam-Mahomed A, Grobusch MP, Gupta R, Harausz E, Harrington M, Horsburgh CR, Lienhardt C, McNeeley D, Mitnick CD, Nachman S, Nahid P, Nunn AJ, Phillips P, Rodriguez C, Shah S, Wells C, Thomas-Nyang'wa B, du Cros P.

Int J Tuberc Lung Dis. 2016 Mar;20(3):290-4. doi: 10.5588/ijtld.15.0490.

11.

Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.

Swaminathan A, du Cros P, Seddon JA, Quinnell S, Bobokhojaev OI, Dusmatova Z, Achar J.

Int J Tuberc Lung Dis. 2016 Apr;20(4):474-8. doi: 10.5588/ijtld.15.0666.

PMID:
26970156
12.

Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.

Bonnet M, Bastard M, du Cros P, Khamraev A, Kimenye K, Khurkhumal S, Hayrapetyan A, Themba D, Telnov A, Sanchez-Padilla E, Hewison C, Varaine F.

Int J Tuberc Lung Dis. 2016 Feb;20(2):177-86. doi: 10.5588/ijtld.15.0962.

PMID:
26792469
13.

Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings.

O'Brien D, Spelman T, Greig J, McMahon J, Ssonko C, Casas E, Mesic A, Du Cros P, Ford N.

J Int AIDS Soc. 2016 Jan 14;19(1):20665. doi: 10.7448/IAS.19.1.20665. eCollection 2016.

14.

Barriers to new drug development in respiratory disease.

Brigden G, du Cros P, Wong S.

Eur Respir J. 2016 Jan;47(1):356-7. doi: 10.1183/13993003.00783-2015. No abstract available.

15.

Progress in Medicine: Experts Take Stock.

PLOS Medicine Editors, Beck A, Birney E, Graeber M, Tumwine J, Hay P, Ahn HS, Patel A, du Cros P, von Seidlein L, Wareham N, Low N.

PLoS Med. 2015 Dec 29;12(12):e1001933. doi: 10.1371/journal.pmed.1001933. eCollection 2015 Dec.

16.

A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children.

Furin J, Mafukidze A, Brigden G, du Cros P, Golin R, Harausz E, Seddon JA, Ustero P, Garcia-Prats AJ.

Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:55-60. doi: 10.5588/ijtld.15.0380.

PMID:
26564544
17.

Generating Evidence to Improve the Response to Neglected Diseases: How Operational Research in a Médecins Sans Frontières Buruli Ulcer Treatment Programme Informed International Management Guidance.

O'Brien DP, Ford N, Vitoria M, Asiedu K, Calmy A, Du Cros P, Comte E, Christinet V.

PLoS Negl Trop Dis. 2015 Nov 12;9(11):e0004075. doi: 10.1371/journal.pntd.0004075. eCollection 2015 Nov. No abstract available.

18.

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.

Achar J, Berry C, Herboczek K, Parpieva N, Tillyashaykhov MN, Tigay ZN, Khamraev A, Velivela K, Seddon JA, du Cros P.

Emerg Infect Dis. 2015 Nov;21(11):2105-6. doi: 10.3201/eid2111.151119. No abstract available.

19.

Challenges and solutions to implementing drug-resistant tuberculosis programmes for children in Central Asia.

du Cros P, Swaminathan A, Bobokhojaev OI, Sharifovna ZD, Martin C, Herboczek K, Höhn C, Seddon JA.

Public Health Action. 2015 Jun 21;5(2):99-102. doi: 10.5588/pha.15.0007.

20.

Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?

Bastard M, Bonnet M, du Cros P, Khamraev AK, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Telnov A, Sanchez-Padilla E, Hewison C, Varaine F.

Am J Respir Crit Care Med. 2015 Jul 1;192(1):117-8. doi: 10.1164/rccm.201504-0747LE. No abstract available.

PMID:
26131996

Supplemental Content

Support Center